Clinical trial
A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus…
NCT00420849 · Celgene Corporation, Industry · Completed
Key facts
| NCT number | NCT00420849 |
|---|---|
| Title | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma |
| Official title | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma |
| Lead sponsor | Celgene Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Lenalidomide, Dexamethasone |
| Enrollment | 587 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 11, 2007 |
| Last update posted | May 21, 2012 |
| Countries | Australia, Austria, Ireland, Spain, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: